Back to dashboard
All PlansAdministrativeMedium impact

Newsletter Vol. 9, No. 01

New Jersey Medicaid·NJ·Provider Notice
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply
—

Summary

New monitoring system implemented for therapeutic duplication (PDUR) to identify when patients receive multiple similar medications that could cause harmful interactions or redundant therapy. This affects prescription-related billing and may impact prior authorization requirements for duplicate therapeutic classes.

Action Required

Action needed
Immediately: Review current prescription billing practices to ensure awareness of new therapeutic duplication monitoring. Coordinate with providers to verify all prescription-related claims align with PDUR guidelines to avoid potential claim reviews or denials for duplicate therapies.

Related policy hubs